Summary
Two continuous human glioma derived cell lines, LI and DF, were established in our laboratory. Both cell lines showed cytological features andin vitro behavior similar to those of the respective original neoplasms. These two lines were characterized for their main biological properties includingin vitro andin vivo growth rate, clonogenic ability and tumorigenicity in nude mice. The plating efficiencies were generally high both during exponential and stationary growth phases and a high tumorigenicity was observed. All injected nude mice developed tumors. The two lines were tested for chemosensitivity to 1,3-bis(2-chloroethyl)-1-1nitrosourea (BCNU) and cis-Diamminedichloroplatinum II (DDP).
Heterogeneity in biological features and in drug sensitivity was observed. Exposure of the two lines to BCNU and DDP showed that the glioblastoma (LI) was less sensitive than the anaplastic astrocytoma (DF). For both lines BCNU was more effective on cells in plateau than in exponential phase, while the killing effect of DDP was not phase-dependent.
Similar content being viewed by others
References
Shapiro WR: Combined modality treatment of malignant glioma. In: Rose FC, Fields WS (eds) Progress in Experimental Tumor Research. Karger Basel, 1985, v. 29, pp 219–224
Feun LG, Lee YY, Wallace S, Charnsaugavej N, Carrasco CH, Gianturco C, Yung WKA: New drugs and new delivery techniques. In: Rose FC, Fields WS (eds) Progress in Experimental Tumor Research. Karger Basel, 1985, v. 29, pp 131–139
Bigner DD, Bigner SH, Pontén J, Westermark B, Mahaley Jr MS, Rouslanti E, Herschman H, Eug LF, Winkstrand CJ: Heterogenicity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. of neuropathology and Experimental neurology. XL n. 33, 1981, pp 201–209
Drewinko B: Use of malignant cell lines in screening. In: Spitzy KH, Karrer KC (eds) 13th International Congress of Chemotherapy 1983 v. 11, 1983, pp 223–1-7
Dean PN, Anderson EC: The rate of DNA synthesis during S phase by mammalian cellsin vitro. In: Haaven CAM, Hiller HFP and Wessels JMC (eds) Pulse Cytophotometry Part I. European Press Medikon, Gent, 1975, pp 77–86
Elkind WM, Withmore GF: Radiobiology of cultured mammalian cells. Gordon and Breach New York, 1967
Markvardt D: An algorithm of least squares estimation of non linear parameters. J Soc Industr Appl Math 11:431–441, 1963
Bertuzzi A, Gandolfi A, Germani A, Vitelli R, Badaracco G, Starace G: DNA synthesis, rate in neoplastic cells in culture. In: Eisenfed J, Witten M (eds) Modelling of Biomedical System. Elsevier Science Publishers B.V. North-Holland, 1986, pp 35–39
Greco C, Candiloro A, Caputo A, Carapella C, Giovanella B, Riccio A, Silvestrini B, Zupi G: Characterization and chemosensitivity of two human glioma derived cell lines (Abstr 98). AACR Proc 27:26, 1986
Drewinko B, Patchen M, Yang L, Barlogie B: Differential killing efficacy of twenty antitumor drugs on proliferating and non proliferating human tumor cells. Cancer Res 41:2328–2333, 1981
Barranco SC, Humphry RM: The effects of 1,3-bis (2 chloroethyl)-1-nitrosurea on survival and cell progression in chinese hamster cells. Cancer Res 31:191–195, 1971
Bhuyan Bk, Fraser TJ, Day KJ: Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells. Cancer Res 37:1057–1063, 1977
Spigelman MK: Current status of chemotherapy for brain tumors and metastases (abstr 16). Proc. Chemoter Found Symp VII: Innovative cancer Chemotherapy for tomorrow: 9–10, 1986
Gerosa MA, Rosenblum ML, Stevanoni G, Licata C, Della Corte V, Marcon C, Bricolo A, Tridente G:In vitro analysis of BCNU-sensitivity in human malignant gliomas. Acta Neurol Scand 76:66–70, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zupi, G., Candiloro, A., Laudonio, N. et al. Establishment, characterization and chemosensitivity of two human glioma derived cell lines. J Neuro-Oncol 6, 169–177 (1988). https://doi.org/10.1007/BF02327393
Issue Date:
DOI: https://doi.org/10.1007/BF02327393